Direct-acting vasodilators: Nursing pharmacology
Revisores de contenido
Direct-acting vasodilators are a class of antihypertensive medications that are used for severe refractory hypertension, malignant hypertension, and hypertensive emergencies. These medications include hydralazine, which can be administered orally, intravenously, and intramuscularly; minoxidil, which can be administered orally or topically; and sodium nitroprusside, which is given intravenously.
Once administered, direct acting vasodilators rapidly work on the vascular smooth muscle cells by preventing the increase of intracellular calcium concentration.
As a result, direct acting vasodilators prevent vasoconstriction and promote vasodilation, leading to a reduction in the total peripheral resistance and blood pressure.
Keep in mind that hydralazine and minoxidil mainly work on arterioles, while sodium nitroprusside works on both arterioles and venules.
Now, since direct acting vasodilators tend to work rapidly, they can result in sudden vasodilation and hypotension. This may lead to side effects, including dizziness, headache, reflex tachycardia, palpitations, and edema.
Other side effects include nausea, vomiting, and gastrointestinal distress. So to counteract side effects like reflex tachycardia and edema, direct acting vasodilators can be used in combination with beta-blockers or diuretics, but under close monitoring for adverse effects.
Now, through an unclear mechanism, hydralazine may trigger a lupus-like syndrome, which can involve multiple organs. Clients may experience severe malaise, myalgia, arthralgia, pericarditis, and hepatosplenomegaly, and upon blood tests, they may present with leukopenia, thrombocytopenia, and positive autoantibodies.
What’s important to keep in mind is that hydralazine-induced lupus-like syndrome mainly affects clients who take higher doses for a prolonged period of time, and can be reversed upon discontinuation of hydralazine.
Regarding minoxidil, an important boxed warning is that it can cause pericardial effusion, which may progress to cardiac tamponade, and it can exacerbate angina pectoris.
| DIRECT-ACTING VASODILATORS | ||
| DRUG NAME | hydralazine (Apresoline), minoxidil (Loniten), sodium nitroprusside (Nipride, Nitropress) *High Alert Medication* | |
| CLASS | Direct-acting vasodilators | |
| MECHANISM OF ACTION | Prevent the increase of intracellular calcium concentration within vascular smooth muscle cells → vasodilation → reduced total peripheral resistance and blood pressure | |
| INDICATIONS |
| |
| ROUTE(S) OF ADMINISTRATION |
| |
| SIDE EFFECTS |
| |
| CONTRAINDICATIONS AND CAUTIONS |
| |
| NURSING CONSIDERATIONS: DIRECT-ACTING VASODILATORS | ||
| ASSESSMENT AND MONITORING | Baseline assessment
Hydralazine IV
Nitroprusside IV
| |
| CLIENT EDUCATION |
Hydralazine
Minoxidil
Nitroprusside
| |
- "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)
- "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
- "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
- "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
- "Impact of Platelet Reactivity in ACS Patients on Clinical Outcomes with Triple Antithrombotic Therapy" Journal of Clinical Medicine (2021)
- "Severe Bradycardia Induced by Sofosbuvir and Amiodarone which Resolved after the Discontinuation of Both Drugs" Intern Med (2020)
- "Nigella Sativa (Black Seeds), A Potential Herb for the Pharmacotherapeutic Management of Hypertension - A Review" Curr Cardiol Rev (2021)
Aún no hay notas para este video
Intenta agregar una nota a continuación